Skip to content

Roflumilast

Roflumilast is a PDE4 inhibitor used to reduce exacerbations in selected severe COPD. Listed uses include Chronic Obstructive Pulmonary Disease.

Daliresp

Chronic Obstructive Pulmonary Disease

500mg

Daliresp is roflumilast 500mg film-coated tablets for chronic obstructive pulmonary disease. A PDE4 inhibitor, so anti-inflammatory rather than bronchodilating.

From$1.04/ tabletView

Key points

  • It is not a bronchodilator or rescue treatment for acute breathlessness.
  • Weight loss, diarrhoea, insomnia and psychiatric effects require monitoring.
  • Suicidal intent or severe worsening breathlessness needs urgent care.

Listings are for comparison and general information; suitability and supply depend on clinician and pharmacy checks, monitoring and prescription requirements.

Important safety checks

Weight, liver function, mood history and strong enzyme interactions require review.

When to seek urgent care

Seek urgent help for suicidal intent, severe mood change, facial swelling, breathing difficulty or rapidly worsening COPD symptoms.

Further reading